HWHong Wang

Hong Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hong Wang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Geng Wang

    Department of Emergency, Laiwu City People's Hospital, No. 001 Xuehu Avenue, North Changshao Road, Laiwu 271100, Shandong, China

    1 shared publication
  • Hua Yang

    Intensive Care Unit, Chiping County People's Hospital, Shandong, China

    1 shared publication
  • Na Liu

    Intensive Care Unit, Shandong Provincial Third Hospital, Shandong, China

    1 shared publication
  • Qiaorong Li

    Department of Intensive Care Unit, Shandong Provincial Third Hospital, No. 12 Central Wuying Hill Road, Jinan 250031, Shandong, China

    1 shared publication

Latest Publications

  • Retracted
    Open Access

    miR-126 Functions as a Tumor Suppressor by Targeting SRPK1 in Human Gastric Cancer

    by Qiaorong Li, Geng Wang, Hong Wang

    The expression of miR-126 and serine‐arginine protein kinase 1 (SRPK1) are linked to tumor development; nevertheless, its role in the tumor growth and invasion of gastric cancer (GC) and the underlying mechanism have not been clarified. Here the expression and role of miR-126 and SRPK1 were investigated in GC tissues and cells by in vitro assay, and then targets of miR-126 were identified by dual-luciferase reporter assay. In this study, miR-126 expression was downregulated and associated with lymph node metastasis and poor prognosis as well as SRPK1 expression. In vitro assay revealed that miR-126 obviously inhibited the proliferative and invasive capabilities of GC cells. The dual-luciferase reporter assay showed that miR-126 targets the 3′-UTR of SRPK1 and downregulates its expression. SRPK1 overexpression promoted cell migration and invasion. In conclusion, the reduced expression of miR-126 is suggestive of the risk of GC recurrence and metastasis, and miR-126 functions as a tumor suppressor by targeting SRPK1 expression in the development of GC.


  • Open Access

    miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R

    by Na Liu, Hua Yang, Hong Wang

    Background: In recent years, the aberrant expression of miR-598 in tumorigenesis has been demonstrated, as well as the fact that the IGF-1R pathway is also involved in the development of human gastric cancer (GC). The present study aimed to investigate the molecular mechanisms underlying miR-598-regulated IGF-1R expression in human GC. Materials and methods: We analyzed the expression of miR-598 and IGF-1R in GC samples and cells, and evaluated the clinical significance of miR-598 and IGF-1R in GC patients. Furthermore, in vitro and in vivo assays were used to investigate the molecular mechanisms of miR-598 and IGF-1R. Results: miR-598 expression was frequently downregulated in GC tissues and cells, and significantly correlated with poor prognosis, vascular invasion, TNM stage, and lymph node metastases as well as IGF-1R expression. The overexpression of miR-598 obviously inhibited cell proliferation, migration, invasion, and induced cell cycle arrest in the G1/S phase, and increased the apoptosis of GC cells. The overexpression of miR-598 also significantly inhibited ERK1/2 and Akt phosphorylation level. In vivo assay validated the inhibitory effect of miR-598 on tumor growth. Further studies showed that miR-598 inhibited IGF-1R protein expression by directly targeting its 3´-UTR. Besides, over-expression of IGF-1R reversed the inhibitory effects of miR-598, while suppression of IGF-1R expression showed inverse effects. Conclusion: miR-598 suppresses GC cell proliferation, migration and invasion by directly targeting IGF-1R expression. Thus, miR-598 may be a useful target for GC patients.